4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-24-006833
President & COO sold 96,950 shares at $10.92 ($1,058,694)
- President & COO acquired 96,950 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric President & COO | 2024-02-09 | Option exercise 10b5-1 | +96,950 | $3.85 | $373,258 | 629,157 | D |
| Venker Eric President & COO | 2024-02-09 | Sale 10b5-1 | −96,950 | $10.92 | $1,058,694 | 532,207 | D |
| Derivatives | |||||||
| Venker Eric President & COO | 2024-02-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −96,950 | 12,526,234 | D | ||
| Open-market sales · 96,950 sh · avg $10.92 · $1,058,694 | |||||||
Loading xslF345X05/form4.xml…